Search Results - "KRASINSKAS, Alyssa"

The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms by Basturk, Olca, Yang, Zhaohai, Tang, Laura H, Hruban, Ralph H, Adsay, Volkan, McCall, Chad M, Krasinskas, Alyssa M, Jang, Kee-Taek, Frankel, Wendy L, Balci, Serdar, Sigel, Carlie, Klimstra, David S

“…The 2010 World Health Organization (WHO) classification recommends that pancreatic neuroendocrine tumors (PanNETs) be graded on the basis of the mitotic rate…”
Get full text

S4567 A Rare Case of Olanzapine-Induced Liver Injury Due to DRESS Syndrome by Patel, Krishna, Das, Rishi, Jafarimehr, Elnaz, Arraj, Patrick, Krasinskas, Alyssa

Get full text

Challenging Topics in Pancreatic Neoplasia by Basturk, Olca, Krasinskas, Alyssa M

“…The 2019 PBPS Companion Society Symposium was titled Challenging Topics in Pancreatic Neoplasia" and consisted of outstanding presentations including 3 talks…”
Get full text

A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas by Basturk, Olca, Hong, Seung-Mo, Wood, Laura D, Adsay, N Volkan, Albores-Saavedra, Jorge, Biankin, Andrew V, Brosens, Lodewijk A.A, Fukushima, Noriyoshi, Goggins, Michael, Hruban, Ralph H, Kato, Yo, Klimstra, David S, Klöppel, Günter, Krasinskas, Alyssa, Longnecker, Daniel S, Matthaei, Hanno, Offerhaus, G. Johan A, Shimizu, Michio, Takaori, Kyoichi, Terris, Benoit, Yachida, Shinichi, Esposito, Irene, Furukawa, Toru

“…International experts met to discuss recent advances and to revise the 2004 recommendations for assessing and reporting precursor lesions to invasive…”
Get full text

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma by Singhi, Aatur D, Krasinskas, Alyssa M, Choudry, Haroon A, Bartlett, David L, Pingpank, James F, Zeh, Herbert J, Luvison, Alyssa, Fuhrer, Kimberly, Bahary, Nathan, Seethala, Raja R, Dacic, Sanja

“…Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for patients with malignant peritoneal mesothelioma has resulted in improved disease…”
Get full text

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy by Pennathur, Arjun, MD, Farkas, Andrew, BA, Krasinskas, Alyssa M., MD, Ferson, Peter F., MD, Gooding, William E., MS, Gibson, Michael K., MD, Schuchert, Matthew J., MD, Landreneau, Rodney J., MD, Luketich, James D., MD

“…Objectives Esophagectomy is the standard treatment for T1 esophageal cancer (EC). Interest in endoscopic therapies, particularly for T1 EC, is increasing. We…”
Get full text

Evaluation and Management of Autoimmune Pancreatitis: Experience at a Large US Center by RAINA, Amit, YADAV, Dhiraj, KRASINSKAS, Alyssa M, MCGRATH, Kevin M, KHALID, Asif, SANDERS, Michael, WHITCOMB, David C, SLIVKA, Adam

“…Autoimmune pancreatitis (AIP) is increasingly recognized as a form of chronic pancreatitis. Systematic evaluation and management of AIP in the United States is…”
Get full text

The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus–associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society by Srivastava, Amitabh, Appelman, Henry, Goldsmith, Jeffrey D, Davison, Jon M, Hart, John, Krasinskas, Alyssa M

“…Barrett esophagus (BE) is a known risk factor for the development of esophageal adenocarcinoma. Pathologists play a critical role in confirming the diagnosis…”
Get full text

Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas: A Clinicopathologic Analysis of 44 Cases by Basturk, Olca, Tang, Laura, Hruban, Ralph H, Adsay, Volkan, Yang, Zhaohai, Krasinskas, Alyssa M, Vakiani, Efsevia, La Rosa, Stefano, Jang, Kee-Taek, Frankel, Wendy L, Liu, Xiuli, Zhang, Lizhi, Giordano, Thomas J, Bellizzi, Andrew M, Chen, Jey-Hsin, Shi, Chanjuan, Allen, Peter, Reidy, Diane L, Wolfgang, Christopher L, Saka, Burcu, Rezaee, Neda, Deshpande, Vikram, Klimstra, David S

“…BACKGROUND:In the pancreas, poorly differentiated neuroendocrine carcinomas include small cell carcinoma and large cell neuroendocrine carcinoma and are rare;…”
Get full text

The Diagnostic Utility of p16 FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial Proliferations by MONACO, Sara E, SHUAI, Yongli, BANSAL, Mona, KRASINSKAS, Alyssa M, DACIC, Sanja

“…Two promising ancillary tests used in the diagnosis of mesothelioma include GLUT-1 immunohistochemical analysis and fluorescence in situ hybridization (FISH)…”
Get full text

Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases by Reid, Michelle D, Balci, Serdar, Ohike, Nobuyuki, Xue, Yue, Kim, Grace E, Tajiri, Takuma, Memis, Bahar, Coban, Ipek, Dolgun, Anil, Krasinskas, Alyssa M, Basturk, Olca, Kooby, David A, Sarmiento, Juan M, Maithel, Shishir K, El-Rayes, Bassel F, Adsay, Volkan

“…Histologic classification of ampullary carcinomas as intestinal versus pancreatobiliary is rapidly becoming a part of management algorithms, with…”
Get full text

Tissue Yield and Diagnostic Efficacy of Fluoroscopic and Cholangioscopic Techniques to Assess Indeterminate Biliary Strictures by Hartman, Douglas J, Slivka, Adam, Giusto, Deborah A, Krasinskas, Alyssa M

“…Background & Aims Evaluation of indeterminate biliary strictures typically involves collection and analysis of tissue or cells. Single-operator, peroral,…”
Get full text

CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival by Krasinskas, Alyssa M, Bartlett, David L, Cieply, Kathleen, Dacic, Sanja

“…Homozygous deletion of CDKN2A (p16) is one of the most common genetic alterations in pleural mesotheliomas, occurring in up to 74% of cases. MTAP resides in…”
Get full text

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer by Boone, Brian A., Steve, Jennifer, Krasinskas, Alyssa M., Zureikat, Amer H., Lembersky, Barry C., Gibson, Michael K., Stoller, Ronald G., Zeh, Herbert J., Bahary, Nathan

“…Background Trials examining FOLFIRINOX in metastatic pancreatic cancer demonstrate higher response rates compared to gemcitabine‐based regimens. There is…”
Get full text

Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols by Eren, Ozgur Can, Bagci, Pelin, Balci, Serdar, Ohike, Nobuyuki, Saka, Burcu, Sokmensuer, Cenk, Leblebici, Can Berk, Xue, Yue, Reid, Michelle D., Krasinskas, Alyssa M., Kooby, David, Maithel, Shishir K., Sarmiento, Juan, Cheng, Jeanette D., Taskin, Orhun Cig, Kapran, Yersu, Tarcan, Zeynep Cagla, Luchini, Claudio, Scarpa, Aldo, Basturk, Olca, Adsay, N. Volkan

“…Background Grade 1/2 PanNETs are mostly managed similarly, typically without any adjunct treatment with the belief that their overall metastasis rate is low…”
Get full text

Assessing treatment effect in pancreatic cancer by Hartman, Douglas J, Krasinskas, Alyssa M

“…Pancreatic cancer is one of the most deadly forms of cancer (43,140 new cases per year; 36,800 deaths), and most people with pancreatic cancer do not survive…”
Get full text

ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B by Eren, Ozgur Can, Bagci, Pelin, Balci, Serdar, Ohike, Nobuyuki, Saka, Burcu, Sokmensuer, Cenk, Leblebici, Can Berk, Xue, Yue, Reid, Michelle D., Krasinskas, Alyssa M., Kooby, David, Maithel, Shishir K., Sarmiento, Juan, Cheng, Jeanette D., Taskin, Orhun Cig, Kapran, Yersu, Tarcan, Zeynep, Luchini, Claudio, Scarpa, Aldo, Basturk, Olca, Adsay, N. Volkan

Get full text

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts by Nikiforova, Marina N, Khalid, Asif, Fasanella, Kenneth E, McGrath, Kevin M, Brand, Randall E, Chennat, Jennifer S, Slivka, Adam, Zeh, Herbert J, Zureikat, Amer H, Krasinskas, Alyssa M, Ohori, N Paul, Schoedel, Karen E, Navina, Sarah, Mantha, Geeta S, Pai, Reetesh K, Singhi, Aatur D

“…With improvements in abdominal imaging, detection of incidental pancreatic cysts are becoming increasingly common. Analysis of pancreatic cyst fluid from…”
Get full text

Rosai-Dorfman Disease of the Pancreas Shows Significant Histologic Overlap With IgG4-related Disease by Tracht, Jessica, Reid, Michelle D, Xue, Yue, Madrigal, Emilio, Sarmiento, Juan M, Kooby, David, Alese, Olatunji B, Krasinskas, Alyssa M

“…Rosai-Dorfman disease (RDD) is a rare entity characterized by proliferating S100-positive histiocytes. Originally described in lymph nodes, it can involve…”
Get full text

Molecular diagnostics of colorectal cancer by Bedeir, Ahmed, Krasinskas, Alyssa M

“…Of all gastrointestinal tract epithelial malignancies, molecular diagnostics has impacted colorectal cancer the most. Molecular testing can detect sporadic and…”
Get full text